Regorafenib is an anti-cancer medication used to treat colorectal cancer. It works by inhibiting tyrosine kinases involved in tumor growth and angiogenesis. Regorafenib is effective for managing advanced cancer. In summary, it is a vital therapy for specific malignancies.
Regorafenib inhibits multiple tyrosine kinases, disrupting signaling pathways that promote tumor growth and angiogenesis.